Quick Answer
BiomX Inc. reported Net Income of -$36.20 million for fiscal year 2025.
BiomX Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$36.20M -104.2% |
-$17.73M +32.3% |
-$26.17M +7.6% |
-$28.32M +21.8% |
-$36.23M -20.4% |
-$30.09M -8760.2% |
| Diluted EPS | $22.19 -61.9% |
$58.31 +1043.3% |
$5.10 +436.8% |
$0.95 -31.7% |
$1.39 | — |
| Total Assets | $5.78M -86.6% |
$43.23M +72.7% |
$25.03M -45.0% |
$45.53M -41.6% |
$77.99M +10.8% |
$70.36M -1.8% |
| Cash and Equivalents | $4.36M -74.1% |
$16.86M +13.1% |
$14.91M -52.4% |
$31.33M -49.5% |
$62.10M +70.2% |
$36.48M +5134.7% |
| Long-Term Debt | — | — | $5.40M -49.0% |
$10.59M -26.5% |
$14.41M | — |
| Stockholders Equity | -$1.30M -105.4% |
$24.15M +683.8% |
$3.08M -85.4% |
$21.04M -55.7% |
$47.53M -17.3% |
$57.47M +1049.4% |
| R&D Expense | $21.29M -13.7% |
$24.66M +47.7% |
$16.70M +2.8% |
$16.24M -28.4% |
$22.68M +16.8% |
$19.42M +43.9% |
| Operating Income | -$41.47M +6.9% |
-$44.52M -75.6% |
-$25.35M +6.9% |
-$27.22M +23.2% |
-$35.46M -17.2% |
-$30.26M -7380.0% |
| Shares Outstanding | 1.59M +55.8% |
1.02M -78.3% |
4.72M -84.2% |
29.98M +0.8% |
29.75M +27.9% |
23.26M +938.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$9.17M | -195.1% | -51.8% |
| Diluted EPS | September 30, 2025 | $0.29 | +193.5% | +52.6% |
| Total Assets | September 30, 2025 | $26.17M | -56.4% | -31.2% |
| Cash and Equivalents | September 30, 2025 | $6.92M | -70.6% | -50.7% |
| Long-Term Debt | December 31, 2023 | $5.40M | -49.0% | -20.7% |
| Stockholders Equity | September 30, 2025 | $10.49M | -72.3% | -45.3% |
| R&D Expense | September 30, 2025 | $6.12M | -15.9% | +22.1% |
| Operating Income | September 30, 2025 | -$8.54M | +24.6% | -14.8% |
| Shares Outstanding | September 30, 2025 | 26.80M | +47.4% | +1.4% |
- BiomX Inc. reported Net Income of -$36.20 million for fiscal year 2025.
- BiomX Inc. showed a decrease of -104.2% in Net Income compared to the prior fiscal year.
- BiomX Inc. reported Diluted EPS of $22.19 per share for fiscal year 2025.
- BiomX Inc. showed a decrease of -61.9% in Diluted EPS compared to the prior fiscal year.
- BiomX Inc. reported Total Assets of $5.78 million for fiscal year 2025.
- BiomX Inc. showed a decrease of -86.6% in Total Assets compared to the prior fiscal year.
- BiomX Inc. reported Cash and Equivalents of $4.36 million for fiscal year 2025.
- BiomX Inc. showed a decrease of -74.1% in Cash and Equivalents compared to the prior fiscal year.
- BiomX Inc. reported Long-Term Debt of $5.40 million for fiscal year 2023.
- BiomX Inc. showed a decrease of -49.0% in Long-Term Debt compared to the prior fiscal year.
- BiomX Inc. reported Stockholders Equity of -$1.30 million for fiscal year 2025.
- BiomX Inc. showed a decrease of -105.4% in Stockholders Equity compared to the prior fiscal year.
- BiomX Inc. reported R&D Expense of $21.29 million for fiscal year 2025.
- BiomX Inc. showed a decrease of -13.7% in R&D Expense compared to the prior fiscal year.
- BiomX Inc. reported Operating Income of -$41.47 million for fiscal year 2025.
- BiomX Inc. showed an increase of +6.9% in Operating Income compared to the prior fiscal year.
- BiomX Inc. reported Shares Outstanding of 1.59 million shares for fiscal year 2025.
- BiomX Inc. showed an increase of +55.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: